期刊文献+

叶酸修饰的G5-PAMAM-D介导HSV-TK/GCV自杀基因系统治疗前列腺癌的体外实验研究 被引量:1

Prostate Cancer Treatment with HSV-TK/GCV Suicide Gene System Mediated by Folate-Modified G5-PAMAM-D: an Experimental Study in vitro
下载PDF
导出
摘要 目的:探讨叶酸修饰的第五代聚酰胺-胺型树枝状聚合物(G5-PAMAM-D-fol)作为基因载体进行前列腺癌自杀基因治疗的可行性。方法:以GS-PAMAM-D-fol为基因载体将含有自杀基因HSV-TK的重组质粒pcDNA3-tk转染至前列腺癌细胞系PC-3和LNCaP,24h后以RT-PCR法检测HSV-TK基因在两种前列腺癌细胞系中的mRNA表达;再次转染后24h,对转染的两种细胞分别给予不同浓度的前体药物更昔洛韦(GCV),48h后采用四甲基偶氮唑盐比色法(MTT法)检测细胞抑制率。结果:RT-PCR结果证明G5-PAMAM-D-fol可将重组质粒pcDNA3-tk转染2种前列腺癌细胞并转录HSV-TK基因。MTT实验反映出A组(G5-PAMAM-D-fol/pcDNA3-tk)对PC-3和LNCaP细胞有明显的杀伤作用,并且比B组(G5-PAMAM-D/pcDNA3-tk)的细胞抑制率更高。C组(G5-PAMAM-D-fol)和D组(GS-PAMAM-D)随着GCV浓度的增加细胞生长并未受到明显的抑制,而且前者并未表现出比后者更明显的细胞杀伤作用。结论:G5-PAMAM-D-fol能够在体外将自杀基因重组质粒成功转入前列腺癌细胞并表达HSV-TK基因,其靶向性强且细胞毒性低。 Objective: To investigate the feasibility of the folate-modified fifth generation polyamido-amine dendrimer (G5-PAMAM-D-fol) as a gene vector in the suicide gene therapy of prostate cancer. Methods: G5-PAMAM-D-fol was used as the gene vector to transfect the recombinant plasmid pcDNA3-tk containing the HSV-TK suicide gene into the prostate cancer cell lines PC-3 and LNCaP. RT-PCR assay was used to detect HSV-TK mRNA expression in the two cells lines 24 hours after transfection. After another 24 hours, the prodrug ganciclovir (GCV) was given to the transfected PC-3 and LNCaP cells at different concentrations. MTT assay was carried out to determine the cell suppression rate 48 hours after GCV was introduced. Results: The RT-PCR and DNA ladder assays confirmed that as a genetic carrier, G5-PAMAM-D-fol could transfect the recombinant plasmid pcDNA3-tk into the two prostate cancer cells lines, PC-3 and LNCaP, and transcribe the HSV-TK gene. MTT assay showed that the two cell lines were significantly inhibited in group A (G5-PAMAM-D-fol/pcD- NA3-tk), and the cell-inhibition rate was higher in group A than in group B (G5-PAMAM-D/pcDNA3-tk). MTT assay also indi- cated that with an increase of the prodrug concentration, cell growth was not obviously suppressed in group C (G5-PAMAM-D-fol) nor in group D (G5-PAMAM-D) and the exterminating effect was not significantly greater in group C than in group D. Conclusions: G5-PAMAM-D-fol can efficiently transfect the recombinant plasmid containing the suicide gene into the prostate cancer cells and express the HSV-TK gene in vitro, with a high targeting success and a low cytotoxicity to the tumor cells.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2010年第11期615-618,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:30770577) 教育部博士学科点专项科研基金资助(编号:20060062007)~~
关键词 基因载体 基因治疗 自杀基因 前列腺癌 Gene vector Gene therapy Suicide gene Prostate cancer
  • 相关文献

参考文献11

  • 1Isaacs JT.New strategies for the medical treatment of prostate cancer[J].BJU Int,2005,96 Suppl 2:35-40.
  • 2赵维明,徐勇,王燕铭,程兆康,于琦,孔德领.新型基因载体G5-PAMAM-D在前列腺癌HSV-tk/GCV自杀基因系统中的应用[J].中国癌症杂志,2007,17(3):225-230. 被引量:3
  • 3Kang C,Yuan X,Li F,et al.Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo[J].J Biomed Mater Res A,2009,93(2):585-594.
  • 4徐文贵,鲍润贤.肿瘤自杀基因靶向治疗的研究进展冰[J].中国肿瘤临床,2009,36(13):777-780. 被引量:3
  • 5Okegawa T,Li Y,Pong RC,et al.The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy[J].Cancer Res,2000,60(18):5031-5036.
  • 6Verma IM,Weitzman MD.Gene therapy:twenty-first century medicine[J].Annu Rev Biochem,2005,74:711-738.
  • 7张维,史清洪.聚酰胺-胺型多聚物作为基因载体的研究现状[J].化学工业与工程,2009,26(2):165-168. 被引量:2
  • 8Choi Y,Thomas T,Kotlyar A,et al.Synthesis and functional evaluation of DNA-assembled polyamidoamne dendrimer clusters for cancer cell-specific targeting[J].Chem Biol,2005,12(1):35-43.
  • 9Wang Y,Kong W,Song Y,et al.Polyamidoamine dendrimers with a modified pentaerythritol core having high efficiency and low cytotoxicity as gene carriers[J].Biomacromolecules,2009,10(3):617-622.
  • 10Tomalia DA,Reyna LA,Svenson S.Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging[J].Biochem Soc Trans,2007,35(Pt 1):61-67.

二级参考文献58

  • 1王佳琼,王自正.基因转移技术与基因靶向性核素治疗[J].国外医学(放射医学核医学分册),2004,28(4):145-149. 被引量:2
  • 2曾赵军,胡维新,李子博,罗赛群.Tet-On在乳腺癌自杀基因治疗中诱导细胞凋亡的实验研究[J].中国肿瘤临床,2006,33(22):1303-1306. 被引量:1
  • 3房娜,徐文贵,于津浦,魏枫,马庆杰,高凤彤.HSV1-tk基因逆转录病毒载体构建、病毒包装及稳定细胞株建立[J].中国老年学杂志,2007,27(6):528-531. 被引量:5
  • 4GLOVER D J, LIPPS H J, JANS D A, et al. Non-viral therapeutic gene expression in humans [J]. Nature Review Genetics, 2005, 6(8): 299-311.
  • 5CALVO M C, THRASHER A, MAVILIO F. The future of gene therapy [J]. Nature, 2004, 427 : 779 - 781.
  • 6TOMALIA D A, BAKER H, DEWALD J. A new class of polymers : Starburst-dendritic macromolecules [ J]. J Polymer, 1985, 17(1): 117-132.
  • 7LOTHIAN M K. A contemporary survey of covalent connectivity and complexity. The divergent synthesis of poly (thioether) dendrimers. Amplified, genealogically directed synthesis leading to the de Gennes Gennes dense packed state [J]. Tetrahedron, 1997, 53:15 495- 15 513.
  • 8EICHMAN J D, BIELINSKA A U. The use of PAMAM dendrimers in the efficient transfer of genetic material into cells [J]. Pharmaceutical Science & Technology Today, 2000, 3(7) : 232 - 245.
  • 9DURAIRAJ C. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats [J]. Biomaterials, 2007, 28: 504-512.
  • 10MINGLU M, YIYUN C. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug [ J]. European Journal of Medicinal Chemistry, 2007, 42:93 - 98.

共引文献5

同被引文献34

  • 1BRAECKMANS K, BUYENS K, NAEYE B, et al. Advanced fluores-cence microscopy methods illuminate the transfection pathway of nucleic acid nanoparticles [ J ]. J Control Release, 2010,148( 1 ) :69-71.
  • 2QUADIR M A, HAAG R. Biofunetional nanosystems based on dendritic polymers [ J ].J Control Release, 2012,161 (2) :484.
  • 3TOMALIA D A, BAKER H, DEWALD J, et al.A newclass of polymers : starburst-dendritic macromolecules [ J ]. Polym, 1985, 17( 1 ) : 117-132.
  • 4SASAKI E, SUEMIZU H, SHIMADA A, et al. Generation of transgenic non-human primates with gennline transmission [ J ]. Nature, 2009,459 ( 7246 ) : 523 -527.
  • 5BAKER J R .Dendrimer-based nanoparticles for cancer therapy [ J] .Hematol Soc Hematol Educ Program,2009( 1 ):708-719.
  • 6SHARMA A, GAUTAM S P, GUPTA A K. Surface modified dendrimers: synthesis and characterization for Cancer targeted drug delivery [ J l-Bioorg Med Chem, 2011,19 ( 11 ) : 3341-3346.
  • 7MUKHERJEE S P, LYNG F M, GATCIA A, et al. Mechanistic studies of in vitro cytotoxicity of poly (amidoamine) dendrimers in mammalian ceils [ J ]. Toxicol Appl Pharmacol, 2010, 248 (3) :259-268.
  • 8PARIMI S, BARNES T J, CALLEN D F, et al. Mechanistic insight into cell growth, Interna-lization, and cytotoxicty of PAMAM dendrimers [ J ]. Biomacromolecules, 2010, 11 ( 2 ) : 382-389.
  • 9XIANG S N, TONG H J, SHI Q, et al. Uptake mechanisms of non- viral gene delivery [ J ]. J Control Release, 2011,158 ( 3 ) : 371.
  • 10QI Rong, GAO Yu,TANG Yin, et al.PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression [ J ].AAPS J, 2009,11 ( 3 ) : 395-405.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部